Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Long-Term Debt : ¥273 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hubei Hongyuan Pharmaceutical Technology Co Long-Term Debt?

Hubei Hongyuan Pharmaceutical Technology Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥273 Mil.

Hubei Hongyuan Pharmaceutical Technology Co's quarterly Long-Term Debt declined from Sep. 2023 (¥306 Mil) to Dec. 2023 (¥276 Mil) and declined from Dec. 2023 (¥276 Mil) to Mar. 2024 (¥273 Mil).

Hubei Hongyuan Pharmaceutical Technology Co's annual Long-Term Debt increased from Dec. 2021 (¥47 Mil) to Dec. 2022 (¥342 Mil) but then declined from Dec. 2022 (¥342 Mil) to Dec. 2023 (¥276 Mil).

Hubei Hongyuan Pharmaceutical Technology Co Long-Term Debt Historical Data

The historical data trend for Hubei Hongyuan Pharmaceutical Technology Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Hongyuan Pharmaceutical Technology Co Long-Term Debt Chart

Hubei Hongyuan Pharmaceutical Technology Co Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

85.89

47.22

341.67

276.12

Hubei Hongyuan Pharmaceutical Technology Co Quarterly Data
	Jun15	Dec15	Jun16	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															338.89	308.89	306.12	276.12	273.34

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Hubei Hongyuan Pharmaceutical Technology Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Hubei Hongyuan Pharmaceutical Technology Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

No. 8, Hongyuan Road, Economic Development Zone, Luotian County, Hubei Province, Fengshan Town, CHN, 438600

Website

http://www.hbhypharm.com

Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Headlines

No Headlines